San Diego Physician Installed as President of the American College of Endocrinology

San Diego Physician Installed as President of the American College of Endocrinology

<0> American Association of Clinical Endocrinologists (AACE)Glenn Sebold, 904-353-7878 </0>

Daniel Einhorn, M.D., F.A.C.P., F.A.C.E., was installed as President of the American College of Endocrinology (ACE) at the in Phoenix, Arizona on Sunday, May 5, 2013.

"People with endocrine diseases need to know that there is an authoritative source for information, and The American College of Endocrinology is that,” Dr. Einhorn said. “I plan to lead the College in accelerating its work in the education and certification of health care professionals to accommodate the ever increasing public health need, especially in diabetes.

“Even as we expand our reach, we must assure that quality is kept at the highest level whatever the challenges in the healthcare environment,” Dr. Einhorn added.

Dr. Einhorn is a clinical endocrinologist with Diabetes and Endocrine Associates, Medical Director of the Scripps Whittier Diabetes Institute, and a Clinical Professor of Medicine at the University of California San Diego.

As ACE President, Dr. Einhorn will preside over all meetings of ACE and the Board of Trustees. He or his designate will act as the principal spokesperson for the College.

Dr. Einhorn was the Guest Editor of the Endocrinology and Metabolism Clinics of North America for “Type 2 Diabetes as a Cardiovascular Disease,” and The Royal Society Press’s “Type 2 Diabetes: Interpreting Results in a Time of Pandemic.” Dr. Einhorn has served on The Endocrine Society’s (TES) Clinical Affairs Committee, the American Diabetes Association (ADA) Managed Care Initiative, and is past Chair of the Diabetes and Pregnancy Program of San Diego and Imperial Counties. He was the endocrinologist representative on the American Medical Association’s (AMA) Diabetes Advisory Council and the current AMA website for diabetes management. He has Chaired Task Forces and Consensus Conferences for AACE/ACE, including The Insulin Resistance Syndrome and Pre-Diabetes.

His research and publication interests include diabetes prevention and reversal, recognition and treatment of diabetic complications, new technologies and pharmaceuticals, combination therapies, and clinical decision-making. He has lectured nationally and internationally on these topics and has chaired meetings of the American Federation of Clinical Research in Carmel, TES Postgraduate Meetings in diabetes, and numerous regional symposia. He consults to and is on Advisory Boards of biotechnology and pharmaceutical companies, and is a reviewer for “Endocrine Practice,” AACE’s peer-reviewed medical journal, “Diabetes Care,” “The American Journal of Medicine,” “The Journal of the American Medical Association,” “The Journal of Endocrinology and Metabolism,” “The Medical Letter,” and “Diabetes Health.”

Dr. Einhorn is an Associate Editor of the “Journal of Diabetes” and on the Editorial Board of “Clinical Endocrinology News.”


Suggested Articles

While it continues to oppose “Medicare for All,” the American Medical Association has dropped out of a coalition organized to fight the proposal.

Experts who examined 21 California cases in which extreme risk protection orders were used suggest they can play a role in preventing mass shootings.

The opioid epidemic prompted some medical centers and groups of physicians to establish surgery-specific prescribing guidelines. How have they worked?